Study evaluating Oral KORSUVA (CR845/difelikefalin) for the treatment of pruritus in patients with primary biliary cholangitis (PBC) Oral KORSUVA is also the subject of a separate, ongoing Phase 2 trial for the treatment of pruritus in stage III-V chronic kidney...
Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a wholly-owned subsidiary of Zenith Capital Corp., announced today that it has dosed the first patient in a Phase 1b/2 clinical trial undertaken in collaboration with Pfizer Inc. (“Pfizer”). The trial will evaluate...
First oral microbiome biologic drug candidate from Assembly’s novel microbiome platform to enter clinical trials in patients ABI-M201 utilizes Assembly’s proprietary and patented Gemicel® capsule-in-capsule delivery system for targeted delivery into the GI tract SAN...
— Yisheng Biopharma Co., Ltd. (“Yisheng Biopharma”), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, announced that it has received Investigational New Drug...
Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that it has enrolled a total of forty (40) patients in its continuing Phase II Clinical Trial for critical limb ischemia (“CLI”) to-date. As previously announced,...
Global study designed to assess the efficacy and safety of suvodirsen in DMD patients amenable to exon 51 skipping Results intended to support regulatory approvals globally Wave Life Sciences Ltd. (WVE), a clinical-stage genetic medicines company committed to...
Email
Text